Events like the ๐๐ฏ๐ค๐ฐ๐ญ๐ฐ๐จ๐บ ๐๐ณ๐ข๐ฏ๐ด๐ง๐ฐ๐ณ๐ฎ๐๐ก๐ช๐ฐ๐ฏ ๐๐ถ๐ฎ๐ฎ๐ช๐ต, hosted today by AstraZeneca in Madrid, are essential for sharing knowledge and fostering collaboration across the oncology community. With a focus on the latest advances in drug development and how to enhance clinical practice through innovative technologies, the event brought together key stakeholders driving the future of #cancercare. This year, our Medical Advisor Almudena Fuster Matanzo represented Quibim in the session โAI in Clinical Practice: Success Storiesโ, joining Siemens and Sycai Medical to highlight disruptive imaging solutions. It was a great opportunity to showcase how innovative tools can unlock the full potential of imaging data and help shape a future where technology and medicine work seamlessly together to transform cancer care. #OncologyInnovation #AIinHealthcare #MedicalImaging
๐ซ๐ท We are looking forward to participate in the 73rd JFR (Journรฉes Francophones de Radiologie) in Paris, which will take place from October 3-6. This is a great opportunity to explore how AI is transforming medical imaging, improving precision, and optimizing #patientcare. Donโt miss Prof. Philippe PUECH's pitch, "QP-Prostateยฎ : Optimiser la dรฉtection du cancer grรขce ร lยดIA", on Friday, October 3rd at 15:05 in the Forum IA. And visit us at booth FIA-10 to meet our expertsโPaul Idelson, Javier Pizcueta Pastor and Claire Palacinโwho will be happy to show you our AI solutions and discuss how advanced image analysis can help radiologists in their daily practice. ๐ Don't forget to book a demo: https://lnkd.in/dZJjS_aH #JFR2025 #Radiology#AIinHealthcare #MedicalImaging #InnovationinHealthcare
๐ Excited to share that Quibim has been recognized as one of the Best Small & Medium Workplaces in Europe 2025! A huge thank you to our incredible team of quibimersโyour passion and dedication are what make this truly a #GreatPlaceToWork! Great Place To Work #TeamCulture #gptw #BestInEurope #GreatPlacetoWork #EuropesBestWorkplaces25
In the healthcare sector, certifications go far beyond regulatory checkboxes - they are a guarantee of safety, performance and trust for both patients and professionals. Josep Hortigรผela, Senior Vice President of Quality Assurance and Regulatory Affairs, took to the stage at the ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ ๐จ๐ซ๐ฎ๐ฆ in Madrid to share Quibim's regulatory journey. In his talk, โ๐๐ฆ๐ฅ๐ช๐ค๐ข๐ญ ๐๐ฐ๐ง๐ต๐ธ๐ข๐ณ๐ฆ. ๐๐ ๐๐ฆ๐ณ๐ต๐ช๐ง๐ช๐ค๐ข๐ต๐ช๐ฐ๐ฏ. ๐๐ฆ๐บ ๐๐ฐ๐ช๐ฏ๐ต๐ด ๐ข๐ฏ๐ฅ ๐๐ฆ๐ด๐ด๐ฐ๐ฏ๐ด ๐๐ฆ๐ข๐ณ๐ฏ๐ฆ๐ฅโ, Josep reflected on Quibim's path โthree CE certifications under the MDR and three FDA clearances for AI-based SaMD solutionsโto reveal what it truly takes to bring certified medical software to market. He emphasized the critical factors for compliance, including lifecycle standards and clinical evaluation, as well as cybersecurity, quality management, and realistic timelines, all essential for delivering safe and effective AI solutions in healthcare. FARMAFORUM 2025 #MedicalDevices #SaMD hashtag#HealthcareInnovation #RegulatoryAffairs #MedTech #PatientSafety
๐๏ธ 1 in 8 men will be diagnosed with #ProstateCancer during their lifetime, and although localized cases have a five-year survival rate of nearly 100%, this figure drops to 32% when the disease spreads. In a recent pharmaphorum article, our CEO & Co-Founder รngel Alberich-Bayarri explores how AI-generated images can transform prostate cancer care, enabling earlier detection, reducing unnecessary biopsies, and offering more personalized treatment. Awareness is important. But innovation is what will change outcomes. https://lnkd.in/ddYj5qqR #ProstateCancerAwareness #AIInHealthcare #MedicalImaging #CancerCare
Weโre always excited to see advancements in prostate cancer detection that donโt require invasive biopsies. In honor of #ProstateCancerAwarenessMonth, weโre pleased to share this study on a promising noninvasive urine test that identifies prostate cancer using three biomarkers: TTC3, H4C5, and EPCAM. The test detects #ProstateCancer with 91% accuracy, even in PSA-negative patients, and can distinguish cancer from benign conditions like BPH and prostatitis. By reducing unnecessary biopsies, it represents a major step toward safer, earlier, and more precise diagnoses. Itโs encouraging to see science opening new paths to earlier, safer, and more precise diagnoses. You can read the full paper here: https://lnkd.in/dtM6gViW #EarlyDetection #MedicalInnovation #HealthcareResearch
Our team members Marta Martinez Calle, Ph.D. and Cristina Lerma Arce are currently participating in the 2025 Annual Conference of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) in Barcelona, Spain. Come by booth #SP02 to learn more about QP-Insights, and don't forget to attend Marta's presentation tomorrow, September 16, from 10:00 to 11:00 a.m., where she will discuss in detail our abstract accepted for this conference: โ๐๐ฏ๐ต๐ฆ๐ณ๐ท๐ฆ๐ฏ๐ต๐ช๐ฐ๐ฏ๐ข๐ญ ๐๐ข๐ฅ๐ช๐ฐ๐ญ๐ฐ๐จ๐บ ๐๐ฎ๐ข๐จ๐ช๐ฏ๐จ ๐๐ญ๐ข๐ต๐ง๐ฐ๐ณ๐ฎ ๐ต๐ฐ ๐ง๐ฐ๐ด๐ต๐ฆ๐ณ ๐๐ถ๐ญ๐ต๐ช-๐๐ฏ๐ด๐ต๐ช๐ต๐ถ๐ต๐ช๐ฐ๐ฏ๐ข๐ญ ๐๐ฆ๐ด๐ฆ๐ข๐ณ๐ค๐ฉ ๐๐ต๐ถ๐ฅ๐ช๐ฆ๐ด ๐ข๐ฏ๐ฅ ๐๐ญ๐ช๐ฏ๐ช๐ค๐ข๐ญ ๐๐ณ๐ช๐ข๐ญ๐ดโ. What a great opportunity to interact with colleagues, share knowledge, and advance research in interventional radiology. #CIRSE2025 #InterventionalRadiology #MedicalImaging #ClinicalResearch #QPInsights
Quibim will be participating in the European Society of Urogenital Radiology (ESUR) 2025 in Stockholm, September 25โ28. Our team โ Lara Hernรกndez, Andrea Lorenzo Polo, and Paul Idelson โ will be there to connect, share insights, and explore the latest in urogenital imaging. Donโt miss our Industry Symposium along Philips "๐๐-๐๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ: ๐๐ฅ๐ท๐ข๐ฏ๐ค๐ช๐ฏ๐จ ๐ฑ๐ณ๐ฆ๐ค๐ช๐ด๐ช๐ฐ๐ฏ ๐๐๐ ๐ข๐ฏ๐ฅ ๐ฅ๐ฆ๐ค๐ช๐ด๐ช๐ฐ๐ฏ ๐ด๐ถ๐ฑ๐ฑ๐ฐ๐ณ๐ต ๐ง๐ฐ๐ณ ๐ฆ๐ข๐ณ๐ญ๐บ ๐ฑ๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ ๐ค๐ข๐ฏ๐ค๐ฆ๐ณ ๐ฅ๐ฆ๐ต๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ", with Prof. Philippe PUECH from CHU de Lille, France. ๐ Friday, September 26 โฐ 12:00 โ 12:30 p.m. ๐ Room C1 + C2 Looking to see our solutions in action? Book a demo and discover how we can transform imaging together: https://lnkd.in/dM9kffFj #ESUR2025 #UrogenitalImaging #MedicalInnovatio
At Quibim, weโve always believed medical images hold far more information than meets the eye. Today, after major collaborative research, weโre proud to share a milestone published in European Radiology: our latest systematic review and meta-analysis, covering data from over 45,000 non-small cell lung cancer (NSCLC) patients, shows that AI applied to routine chest CT scans can predict key tumor mutations such as EGFR, ALK, and KRAS. This finding has the potential to support treatment decisions by prioritizing patients with the highest mutation likelihood, minimizing delays in targeted therapies, and optimizing healthcare resources without compromising quality. Weโre deeply grateful to our incredible team and partners who made this breakthrough possible. This is just the beginning of transforming everyday medical images into powerful tools for precision oncology. https://bit.ly/4mcUpU2 #AI #mutationstatus #NSCLC #Medicalimaging #radiomics #lungcancer #radiology
๐ We're live at the 42nd World Congress of Endourology and Urotechnology (WCET) in Phoenix! Come meet our expertsโDavid Bazaga, Nathan Clark, Joshua Moss, Edward Ramirez R.T. (R)(MR) B.S., and Eric Draperโto discover how AI is advancing the treatment of #ProstateCancer, enabling precision in fusion biopsy and focal therapy, and transforming clinical decision-making. Don't miss the opportunity to see our solutions in actionโvisit us at our booth. Book a demo: https://lnkd.in/dGsVHEhf #WCET2025 #Urology #AIinHealthcare #MedicalImaging #HealthcareInnovation
